Polymorphisms and haplotypes of the DRD2 gene are associated with negative symptom treatment response to amisulpride

被引:0
作者
Lee, J. H. [1 ]
Lee, K. H. [2 ]
Kang, S. G. [3 ]
Chee, I. S. [4 ]
机构
[1] Catholic Univ Daegu, Sch Med, Dept Psychiat, Daegu, South Korea
[2] Dongguk Univ, Coll Med, Dept Psychiat, Gyeongju, South Korea
[3] Gachon Univ, Dept Psychiat, Gil Med Ctr, Inchon, South Korea
[4] Chungnam Natl Univ, Dept Psychiat, Inst Brain Res, Daejeon, South Korea
关键词
SCHIZOPHRENIC-PATIENTS; RECEPTOR; DOPAMINE-D-2;
D O I
10.1016/S0924-977X(14)70235-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.1.a.004
引用
收藏
页码:S155 / S155
页数:1
相关论文
共 3 条
  • [1] Genetic polymorphisms of the dopamine D2 and D3 receptor and neuroleptic drug effects in schizophrenic patients
    Dahmen, N
    Müller, MJ
    Germeyer, S
    Rujescu, D
    Anghelescu, I
    Hiemke, C
    Wetzel, H
    [J]. SCHIZOPHRENIA RESEARCH, 2001, 49 (1-2) : 223 - 225
  • [2] Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics
    Ritchie, T
    Noble, EP
    [J]. NEUROCHEMICAL RESEARCH, 2003, 28 (01) : 73 - 82
  • [3] The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients
    Suzuki, A
    Mihara, K
    Kondo, T
    Tanaka, O
    Nagashima, U
    Otani, K
    Kaneko, S
    [J]. PHARMACOGENETICS, 2000, 10 (04): : 335 - 341